Laura Platon
Overview
Explore the profile of Laura Platon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tchakerian S, Besnard N, Brunot V, Moulaire V, Benchabane N, Platon L, et al.
Pneumonia (Nathan)
. 2024 Nov;
16(1):27.
PMID: 39497221
Objective: The aim of this study was to describe the characteristics of patients admitted to the intensive care unit with severe pneumonia due to SARS-CoV-2, comparing them according to successive...
2.
Lafarge A, Dupont T, Canet E, Moreau A, Picard M, Mokart D, et al.
Am J Respir Crit Care Med
. 2024 Jul;
210(8):1017-1024.
PMID: 39018219
Allogeneic hematopoietic stem-cell transplantation (Allo-HSCT) recipients are still believed to be poor candidates for ICU management. We investigated outcomes and determinants of mortality in a large multicenter retrospective cohort of...
3.
Larcher R, Bargnoux A, Badiou S, Besnard N, Brunot V, Daubin D, et al.
Ren Fail
. 2023 Dec;
45(2):2292152.
PMID: 38078385
Tubular injury is the main cause of acute kidney injury (AKI) in critically ill COVID-19 patients. Proximal tubular dysfunction (PTD) and changes in urinary biomarkers, such as NGAL, TIMP-2, and...
4.
Baucher L, Lemiale V, Joseph A, Wallet F, De Chambrun M, Ferre A, et al.
Ann Intensive Care
. 2023 Dec;
13(1):123.
PMID: 38055081
Background: In the last decade, Ibrutinib has become the standard of care in the treatment of several lymphoproliferative diseases such as chronic lymphocytic leukemia (CLL) and several non-Hodgkin lymphoma. Beyond...
5.
Tournayre S, Mathieu O, Villiet M, Besnard N, Brunot V, Daubin D, et al.
Int J Antimicrob Agents
. 2023 May;
62(2):106868.
PMID: 37244425
Objectives: The use of extended intermittent infusion (EII) or continuous infusion (CI) of meropenem is recommended in intensive care unit (ICU) patients, but few data comparing these two options are...
6.
Huby S, Gelisse P, Tudesq J, Labauge P, Duflos C, Cartron G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Apr;
10(4).
PMID: 37059470
Background And Objectives: Chimeric antigen receptor (CAR) T-cell therapies have dramatically improved the prognosis of patients with relapsed or refractory hematologic malignancies; however, cytokine release syndrome and immune effector cell-associated...
7.
Buzancais A, Brunot V, Larcher R, Tudesq J, Platon L, Besnard N, et al.
Artif Organs
. 2022 Dec;
47(6):999-1006.
PMID: 36527419
Background: A higher sodium (Na) dialysate concentration is recommended during renal replacement therapy (RRT) of acute kidney injury (AKI) to improve intradialytic hemodynamic tolerance, but it may lead to Na...
8.
Lamure S, Van Laethem F, de Verbizier D, Lozano C, Gehlkopf E, Tudesq J, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503088
CD19-directed CAR T-cells have been remarkably successful in treating patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and transformed follicular lymphoma (t-FL). In this cohort study, we treated 60...
9.
Morel G, Mulier G, Ghrenassia E, Abdel Nabey M, Tandjaoui Y, Kouatchet A, et al.
Emerg Infect Dis
. 2021 Jun;
27(7):1840-1849.
PMID: 34153220
No abstract available.
10.
Larcher R, Platon L, Amalric M, Brunot V, Besnard N, Benomar R, et al.
J Fungi (Basel)
. 2021 Apr;
7(5).
PMID: 33923333
Comprehensive data on emerging invasive fungal infections (EIFIs) in the critically ill are scarce. We conducted a case-control study to characterize EIFIs in patients admitted to a French medical ICU...